Medical Journals

Rho Kinase Activation Plays a Major Role As a Mediator of Irreversible Injury in Reperfused Myocardium.

Authors:
  • Hamid Shabaz A
  • Bower Hugo S
  • Baxter Gary F

From: Royal Veterinary College, University of London, London, UK.

American journal of physiology. Heart and circulatory physiology

  • Publish Date: Jun 2007
  • ISSN: 0363-6135
  • Volume: 292
  • Issue: 6
  • Pages: H2598-606
  • Medium: Print
  • Language: English
  • Citation (JAMA): Hamid Shabaz A, Bower Hugo S, Baxter Gary F, et al. Rho Kinase Activation Plays a Major Role As a Mediator of Irreversible Injury in Reperfused Myocardium.. Am. J. Physiol. Heart Circ. Physiol. Jun 2007;292:H2598-606

Abstract

Intracellular signal transduction events in reperfusion following ischemia influence myocardial infarct development. Here we investigate the role of Rho kinase (ROCK) activation as a specific injury signal during reperfusion via attenuation of the reperfusion injury salvage kinase (RISK) pathway phosphatidylinositol 3-kinase (PI3K)/Akt/endothelial nitric oxide (NO) synthase (eNOS). Rat isolated hearts underwent 35 min of left coronary artery occlusion and 120 min of reperfusion. Phosphorylation of the ROCK substrate protein complex ezrin-radixin-moesin, assessed by immunoblotting and immunofluorescence, was used as a marker of ROCK activation. Infarct size was determined by tetrazolium staining, and terminal dUTP nick-end labeling (TUNEL) positivity was used as an index of apoptosis. The ROCK inhibitors fasudil or Y-27632 given 10 min before ischemia until 10 min after reperfusion reduced infarct size (control, 34.1 +/- 3.8%; 5 microM fasudil, 18.2 +/- 3.1%; 0.3 microM Y-27632, 19.4 +/- 4.4%; 5 microM Y-27632, 9.2 +/- 2.9%). When 5 microM Y-27632 was targeted specifically during early reperfusion, robust infarct limitation was observed (14.2 +/- 2.6% vs. control 33.4 +/- 4.4%, P<0.01). The protective action of Y-27632 given at reperfusion was attenuated by wortmannin (29.2 +/- 6.1%) and N(omega)-nitro-L-arginine methyl ester (30.4 +/- 5.7%), confirming a protective mechanism involving PI3K/Akt/NO. Ezrin-radixin-moesin phosphorylation in risk zone myocardium confirmed early and sustained ROCK activation during reperfusion and its inhibition by Y-27632. Inhibition of ROCK activation at reperfusion reduced the proportion of TUNEL-positive nuclei in the infarcted region. In conclusion, ROCK activation occurs specifically during early reperfusion. Inhibition of ROCK at reperfusion onset limits infarct size through an Akt/eNOS-dependent mechanism, suggesting that ROCK activation at reperfusion may be deleterious through suppression of the RISK pathway.

Mesh Headings (Keywords): 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine, 1-Phosphatidylinositol 3-Kinase, Amides, Androstadienes, Animals, Apoptosis, Cardiotonic Agents, Coronary Circulation, Cytoskeletal Proteins, Enzyme Activation, Intracellular Signaling Peptides and Proteins, Male, Membrane Proteins, Microfilament Proteins, Multiprotein Complexes, Myocardial Infarction, Myocardial Reperfusion Injury, Myocardium, NG-Nitroarginine Methyl Ester, Nitric Oxide, Nitric Oxide Synthase Type III, Phosphorylation, Protein Kinase Inhibitors, Protein-Serine-Threonine Kinases, Proto-Oncogene Proteins c-akt, Pyridines, Rats, Rats, Sprague-Dawley, Signal Transduction, rho-Associated Kinases


Check for Full Text / PubMed Unique Identifier (PMID): 17220176


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.